High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo

BACKGROUND: The strong association between aberrant HDAC activity and the occurrence of cancer has led to the development of a variety of HDAC inhibitors (HDIs), which emerge as promising new targeted anticancer therapeutics. METHODS: Due to the pivotal role of RelA/p65 in the tumorigenesis of pancr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehmann, Annika, Denkert, Carsten, Budczies, Jan, Buckendahl, Ann-Christin, Darb-Esfahani, Silvia, Noske, Aurelia, Müller, Berit Maria, Bahra, Marcus, Neuhaus, Peter, Dietel, Manfred, Kristiansen, Glen, Weichert, Wilko
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779818/
https://www.ncbi.nlm.nih.gov/pubmed/19912635
http://dx.doi.org/10.1186/1471-2407-9-395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779818/
https://www.ncbi.nlm.nih.gov/pubmed/19912635
http://dx.doi.org/10.1186/1471-2407-9-395

Ejemplares similares